Endogene

B2B2C company is developing a new quick, non-invasive, and affordable diagnosis for endometriosis using epigenetics.

We have participated because the company operates in a COVID impacted sector.

Zubi Capital Asset Management lanza el primer fondo de venture capital de impacto en diversidad e inclusión en España

Zubi Capital Asset Management launches the first diversity and inclusion impact venture capital fund in Spain

Leer más
Read more